the present invention relates to the field of anti - inflammatory substances , and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins . in some embodiments , methods for treating selectin mediated disorders are provided which include administration of compound of formula i : wherein the constituent variables are defined herein .